A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Phase 1	2026-09-25		NCT06470438

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
A O U Sant Orsola Malpighi	Bologna	Italy	10
Aidport Sp Z O O	Skorzewo	Poland	4
Ankara Universitesi Hastaneleri Tibbi Farmakoloji Anabilim Dali Faz 1 Klinik Arastirma Merkezi	Ankara	Turkey (Türkiye)	3
Beijing Cancer hospital	Beijing	China	84
Fudan University Shanghai Cancer Center	Shanghai	China	83
Koc Universitesi Hastanesi Faz 1 Klinik Arastirma Merkezi	Istanbul	Turkey (Türkiye)	3
Linkou Chang Gung Memorial Hospital	Taoyuan	Taiwan	7
National Cancer Center Hospital	Chūōku	Japan	7
National Cancer Center Hospital East	Kashiwa	Japan	30
National Taiwan University Hospital	Taipei	Taiwan	6
Pratia Onkologia Katowice	Katowice	Poland	9
Samsung Medical Center	Seoul	South Korea	375
SBU Ankara Dr. Abdurrahman Yurtaslan Onkoloji Egitim ve Arastirma Hastanesi Faz 1 Merkezi	Ankara	Turkey (Türkiye)	2
Seoul National University Hospital	Seoul	South Korea	393
Sun Yat Sen University Cancer Center	Guangzhou	China	2
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Klinika Hematologii i Transplantacji Szpiku	Kielce	Poland	1
The Cancer Institute Hospital of JFCR	Tokyo	Japan	16
The First Affiliated Hospital Zhejiang University College of Medicine	Hangzhou	China	1
Tianjin Medical University Cancer Institute and Hospital	Tianjin	China	1